Bacterial vaccines for fish - An update of the current situation worldwide

被引:0
|
作者
Hastein, T [1 ]
Gudding, R [1 ]
Evensen, O [1 ]
机构
[1] Natl Vet Inst, NO-0033 Oslo, Norway
来源
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
During the last few years, the use of vaccines for disease prevention in aquaculture has expanded both with regard to the number of fish species and number of microbial diseases. According to the responses to a questionnaire received from 41 countries, vaccination is used in the commercial aquaculture of species like Atlantic salmon (Salmo salar), rainbow trout (Oncorhynchus mykiss), sea bass (Dicentrarchus labrax), sea bream (Sparus aurata), barramundi (Lates calcarifer), tilapia (Tilapia spp), turbot (Scophthalmus maximus L.), yellowtail (Seriola quinqueradiata), purplish and gold-striped amberjack (Seriola dumereli), striped jack (Pseudocaranx dentex) and channel catfish (Ictalurus punctatus). The range of bacterial infections for which vaccines are commercially available now comprises classical vibriosis (Listonella anguillarum, Vibrio ordalii), furunculosis (Aeromonas salmonicida subsp. salmonicida), cold-water vibriosis (Vibrio salmonicida), yersiniosis (Yersinia, ruckeri), pasteurellosis (Photobacterium damselae supsp. piscicida), edwardsiellosis (Edwardsiella ictaluri), winter ulcer (Moritella viscosa), and streptococcosis/lactococcosis (Streptococcus iniae, Lactococcus garviae). Furthermore, experimental vaccines are used against diseases such as infection with Vibrio harveyi and Photobacterium damsela subsp. damsela in barramundi, piscirickettsiosis and bacteria(kidney disease in salmonids, as well as infection with Flexibacter maritimus (now: Tenacibaculum maritimum) in turbot. There was good agreement between the information received from different sources in the same country. Most vaccines are licensed products, but some non-licensed vaccines are also used in commercial fish farms. Most bacterial vaccines are inactivated products and recombinant vaccine technology has so far been used to a very limited extent. Salmonid fish are usually immunised with multivalent vaccines by intraperitoneal injection. in marine fish species vaccination is generally performed by immersion, but use of injection vaccination is increasing, particularly in the Mediterranean region. Only limited use of orally administered fish vaccines is reported. In general, the effect of vaccination against bacterial infections is good. The best protection is obtained with injectable, adjuvanted vaccines. However, injection-site adverse reactions often occur when such products are used.
引用
收藏
页码:55 / 74
页数:20
相关论文
共 50 条
  • [31] Live vaccines against bacterial fish diseases: A review
    Mohd-Aris, Aslizah
    Muhamad-Sofie, Mohd Hafiz Ngoo
    Zamri-Saad, Mohd
    Daud, Hassan Mohd
    Ina-Salwany, Md. Yasin
    VETERINARY WORLD, 2019, 12 (11) : 1806 - 1815
  • [32] CURRENT AND FUTURE VACCINES FOR PREVENTION OF BACTERIAL DISEASES
    SMITH, DH
    PETER, G
    PEDIATRIC CLINICS OF NORTH AMERICA, 1972, 19 (02) : 387 - &
  • [33] CURRENT TRENDS AND ADVANCES IN BACTERIAL VACCINES TODAY
    WALKER, PD
    JOURNAL OF APPLIED BACTERIOLOGY, 1987, 62 (01): : 1 - 23
  • [34] Epidemiologie der TuberkuloseAktuelle Situation in Deutschland und weltweitEpidemiology of tuberculosisThe current situation in Germany and worldwide
    S. Castell
    B. Hauer
    B. Brodhun
    W. Haas
    Der Pneumologe, 2011, 8 (1): : 9 - 16
  • [35] The Current Update of Vaccines for SARS-CoV-2
    Hoang Duc Ha
    Nguyen Minh Duc
    Pham Minh Thong
    ELECTRONIC JOURNAL OF GENERAL MEDICINE, 2020, 17 (05):
  • [37] Allergy to COVID-19 vaccines: A current update
    Cabanillas, Beatriz
    Novak, Natalija
    ALLERGOLOGY INTERNATIONAL, 2021, 70 (03) : 313 - 318
  • [38] Vitamin D deficiency 2.0: an update on the current status worldwide
    Karin Amrein
    Mario Scherkl
    Magdalena Hoffmann
    Stefan Neuwersch-Sommeregger
    Markus Köstenberger
    Adelina Tmava Berisha
    Gennaro Martucci
    Stefan Pilz
    Oliver Malle
    European Journal of Clinical Nutrition, 2020, 74 : 1498 - 1513
  • [39] Vitamin D deficiency 2.0: an update on the current status worldwide
    Amrein, Karin
    Scherkl, Mario
    Hoffmann, Magdalena
    Neuwersch-Sommeregger, Stefan
    Koestenberger, Markus
    Berisha, Adelina Tmava
    Martucci, Gennaro
    Pilz, Stefan
    Malle, Oliver
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2020, 74 (11) : 1498 - 1513
  • [40] Leishmania Vaccines: the Current Situation with Its Promising Aspect for the Future
    Dinc, Rasit
    KOREAN JOURNAL OF PARASITOLOGY, 2022, 60 (06): : 379 - 391